MSD says the new Bravecto Care Programme involves collaborating with charitable organisations and raising awareness of their mission in order to help save and improve lives of dogs and cats around the world.
StreetVet has become the first of these partnerships for MSD Animal Health in the UK, which will be supplying the charity with Bravecto and Nobivac vaccines.
Amanda Melvin, Marketing Manager for MSD Animal Health Companion Animal said: "The bond between people and their dogs can be a profound one so supporting StreetVet is a perfect collaboration for us through our Bravecto Care Programme . Every vet and vet nurse will understand the value of this vital human animal bond and our team at MSD Animal Health is excited to be providing product and looking forward to volunteering on the streets with the StreetVet team."
StreetVet co-founder Jade Statt said: "Life on the streets makes it difficult for these owners to access the care they need for their dogs, so to ensure the health and vitality of these pets we need to go to them. Having the support of MSD Animal Health helps make that care work easier and allows us to access even more homeless people as the problem grows."
For more information, visit: www.streetvet.co.uk.
This is the second time Hayley has picked up a gong in recognition of her contribution to the veterinary profession: in 2014, she earned the RCVS Golden Jubilee Award for her teaching, clinical and international outreach work.
The RCVS has added its congratulations. Liz Cox, Chair of Veterinary Nurses Council, said: "It is wonderful to see Hayley once again so publicly honoured for her dedication to educating student veterinary surgeons and veterinary nurses at the University of Edinburgh and to helping animals in the UK and internationally both through her day job and her voluntary work.
"This honour truly highlights the importance of the work carried out by veterinary nurses in caring for animals and providing education on animal health and welfare issues and I hope it inspires other veterinary nurses to take pride in their work and their achievements."
The recording of the VPMA’s GDPR webinar with the Information Commissioner's Office has been made available to the veterinary profession to help practices get ready for the 25th May 2018, when the new regulations come into force.
For access to the webinar, email: secretariat@vpma.co.uk
Two winners will be flown from a London airport to spend 2 nights at the Krka Terme Hotel Svoboda Strunjan, a night at the Grand Union Hotel Ljubljana and a night at the Grand Hotel Bled, plus car hire.
To enter, visit www.discoverkrka.co.uk and pick out the differences between the Dalmations.
Ned Flaxman from Krka said: "I’ve only recently joined KRKA and I’m sure like many people I imagined Slovenia to be some far-off country in Eastern Europe. But it’s much closer than you might think - being only a couple hour’s boat ride from Venice.
"I would urge anyone to enter the competition to be in with the chance of winning this truly memorable trip. From the cliffs and stunning beaches of Strunjan to the lively and beautiful city of Ljubljana, Slovenia is a hidden gem just waiting to be discovered."
David, who is Head of Clinical Intelligence at Vets Now, came in eighth place with 1,756 votes in this year’s RCVS Council elections.
The place was originally offered to Dr Tom Witte, who came in seventh place. However, due to a change in personal circumstances, he decided not to accept.
Professor Stephen May, RCVS President, said: "The loss of such a young, talented and respected Council member as Sarah has been difficult to come to terms with and she is greatly missed by her fellow Council members and others amongst the profession.
"It is also important to recognise that the New Year will bring us fresh challenges and opportunities and we will face them best with a full complement of Council members. Therefore, I am delighted that David will be joining Council from January and is able to attend his first Council meeting, which will be held in committee, with us on Thursday 18 January.
"The circumstances under which David will be joining us have been extremely sad, but I am sure he will be an excellent addition to our team and I look forward to working with him."
More information about David Leicester, including his candidate biography and manifesto, can be found in the Council election booklet sent out earlier this year and available to download from www.rcvs.org.uk/publications. A video of David talking about what he would bring to RCVS Council can also be found on the College’s YouTube channel: www.youtube.com/rcvsvideos
The committee considered 5 separate charges against Dr Radev, relating to his treatment of a Yorkshire Terrier and Shih Tzu cross called Pickles at a Vets4Pets veterinary practice in Oxford between 5 October 2015 and 1 November 2015. The charges related to Dr Radev failing to provide adequate and/or appropriate care to the animal and failure to keep detailed clinical records.
After hearing the evidence from Dr Radev and the complainant, the College submitted that it wished to withdraw charges 1(i) and 1(ii) on the basis of insufficient evidence. In addition, Dr Radev had already admitted charges: 1(iii)(b), 1(iv)(d), 1(v), 4(i)(a) and 4(ii)(a) but denied the remaining charges. Of these remaining charges the Committee found charges 1(iv)(a), 2(i), 2(iv), 3(i) and 3(ii) proven with the rest not being proven.
The charges admitted or found proven were that Dr Radev:
(1) On 5 October 2015, failed to provide adequate and/or appropriate care and/or treatment to Pickles, more particularly in that he:
(iii) Failed to offer and/or undertake adequate investigations into Pickles’ condition, more particularly in that he failed to offer and/or undertake:
(b) urine tests;
(iv) Failed to put in place and/or document an adequate management plan for Pickles, more particularly in relation to:
(a) adequate direction and/or advice regarding a review of Pickles’ condition within a clearly defined number of days;
(d) collection of urine at home for analysis on review at the practice;
(v) Having noted that he suspected renal disease, prescribed meloxicam when the same was contraindicated for dogs with renal disease;
(2) On 28 October 2015, failed to provide adequate and/or appropriate care and/or treatment to Pickles, more particularly in that he:
(i) Failed to take and/or record an adequate history from Mrs Pancott in relation to Pickles’ condition and/or clinical signs since 5 October 2015;
(iv) Failed to provide adequate direction and/or advice regarding a date for a review of Pickles’ condition within a clearly defined number of days;
(3) On 30 October 2015, having been informed that Mrs Pancott had telephoned the practice with concerns about Pickles, including blood in the faeces;
(i) Failed to note the matter in Pickles’ medical records;
(ii) Failed to take sufficient steps to obtain more information from Mrs Pancott or to ensure that Mrs Pancott was advised to seek veterinary attention for Pickles in relation to her concerns;
(4) On 1 November 2015, failed to provide adequate and/or appropriate care and/or treatment to Pickles, more particularly in that he:
(i) Failed to interpret the blood tests adequately and/or take appropriate and adequate action in relation to the results of those blood tests, more particularly with regards to:
(a) blood glucose;
(ii) Failed to offer and/or undertake adequate investigations into Pickles’ condition, more particularly in that he failed to:
(a) offer and/or undertake urine tests.
In considering these charges the Disciplinary Committee found that only charge 4(ii)(a) – namely the failure to correctly interpret and act upon the results of a blood glucose test – amounted to serious professional conduct with the rest not passing the threshold of disgraceful conduct in a professional respect. The Committee did not consider that in addition the cumulative effect of all the proven charges taken together amounted to serious professional misconduct.
In relation to the cumulative effect of all the proven charges Professor Alistair Barr, chairing the Committee and speaking on its behalf, said: "The Committee noted that Dr Radev had made errors in relation to one patient but on four separate occasions. These were, for the most part, individual failures at the lower end of the scale of seriousness. Taking into account all of the failings, the Committee in its judgement did not consider that the nature and number of errors and the period of time over which they took place justified a cumulative finding of disgraceful conduct."
In considering the sanction for Dr Radev the Committee took into account a number of mitigating circumstances including the fact that Dr Radev had undertaken suitable training and development in the areas in which he made mistakes, had demonstrated good insight into his conduct and had made some open and frank admissions early on in proceedings. It also considered that the one charge that was found to be serious professional misconduct was a single, isolated mistake linked to Dr Radev’s inexperience.
Professor Barr said: "The Committee considered that taking ‘no further action’ was appropriate and proportionate having considered the history of the case, the Committee’s overall findings and the good reports of Dr Radev’s performance in the two years since the matter which had led to the finding of disgraceful conduct in a professional respect."
The decision to take no further action was also influenced by the length of time it had taken the charges to be heard by the Committee, the positive character references about Dr Radev from professional colleagues and the fact he was unlikely to repeat such conduct in the future.
Proposals being considered include insisting that dog breeders only sell puppies they have bred themselves and demanding that puppies are shown alongside their mother before sale.
Another proposal is to make it illegal to complete the sale of a puppy unless the new owner is present, thereby preventing online sales.
In addition, the government plans to regulate the advertising of all pets, making it a requirement for licensed sellers to display their licence number, the country of origin and the country of residence of any pet advertised for sale.
Measures to tackle puppy smuggling across borders will also be explored, alongside measures to address the breeding of dogs with harmful genetic disorders.
The Government says legislation introducing these proposals could be brought forward early in the New Year.
Prime Minister Theresa May said: "Any unscrupulous mistreatment of animals is disturbing – so in our drive to achieve the highest animal welfare standards in the world, we continually look at what more can be done. The arrival of a happy, healthy puppy, as I know myself, is a memorable time for a family – but it’s absolutely right we do everything we can to eradicate animal cruelty from our society. The proposals my government is developing will be an important step forward."
Environment Secretary Michael Gove said: "At this time of year it is all too easy to be moved by images online or adverts in the local press advertising new born puppies looking for a home for Christmas. But what we don’t see is all too often a sad history of mistreatment and malpractice. That is why we are looking at how we can go further to crack down on unscrupulous breeders so pet owners will have no doubt their new dogs have had the right start in life.
"This is one part of our efforts to ensure we have the highest animal welfare standards in the world. We have also ensured CCTV cameras will be mandatory in all slaughterhouses and will increase prison sentences from six months to five years for animal abusers."
In addition, the Government has confirmed that it will be taking forward proposals already put out for consultation earlier this year. They include a ban on the sale of puppies and kittens under the age of eight weeks, which will now extend to include rabbits, as well as compulsory licensing for anyone in the business of breeding and selling dogs.
Photo: Litter of Terrier Mix Puppies Playing in Dog Bed Outside on Wooden Deck, Shutterstock/Anna Hoychuk
IMV says it has acquired BCF to widen its offering in the reproduction management sector, particularly in imaging. As part of this strategy the company acquired ECM, a French veterinary ultrasound manufacturer, last June, and has launched AlphaVision, a video-assisted bovine insemination system.
Alan Picken, Managing Director of BCF, will lead the imaging division of IMV Technologies and become a member of the Management Board of the Group.
Philippe Gravier, Chief Executive Officer of IMV Technologies, said: "For over 50 years, IMV has been at the forefront of innovations in animal artificial insemination and embryo transfer. Following the acquisition of ECM earlier this year, the integration of BCF supports our vision to supply health status and reproduction-readiness tools to veterinarians, breeding technicians and livestock owners.
"I am very excited that BCF is joining the IMV Technologies Group. Our 100 employees have worked hard to build this company to where it is now. There is no doubt that IMV’s strong brand, customer loyalty and extensive distribution network will help to expand further our imaging activities. Like IMV, I share the vision that market differentiation is in supporting customers to improve animal care, achieved through constant innovation and marketing leading products and services."
Sponsored by Boehringer Ingelheim, the Practice Marketing Award is free to enter, and open only to veterinary practices.
Entries need to demonstrate initiative and/or innovation in the marketing of the practice's services and/or products to clients or the general public during 2017. Eligible entries for the award can include: display advertising, direct mail or electronic media, such as email or websites.
VMA Awards Chair Claire Edmunds said: "Practices have often done a much better job of marketing than they think! And even if they don’t win, entering is great experience and the awards event provides an opportunity to network in the profession. As marketing is becoming an ever more important component in practice success, we would like to encourage as many practices as possible to enter the award."
Last year’s winner Vicky Scutt, joint owner and senior vet at Whitstable Bay Veterinary Centre, said: "Winning the Practice Marketing Award is a real highlight of my career so far! Receiving such a prestigious national award for our practice marketing proves the importance of staying true to your beliefs in business. It gave us the confidence to keep to the same message - because it's clearly working!"
The deadline for submissions is of 2nd February 2018, and the awards are presented on 16th March 2018 in the newly refurbished 5-star Royal Lancaster London hotel.
To enter the Practice Marketing Award, visit: https://www.vma.org.uk/vma-award-categories/practice-marketing-award-entry/
To book event tickets, visit: http://www.vma.org.uk/events/vma-annual-advertising-awards/
For any other information, visit: www.vma.org.uk, email: secretary@vma.org.uk or telephone 0330 223 2259.
Dechra Brand Manager Craig Sankey said: "It can be a very worrying time for owners if their pet is being investigated for, or diagnosed with, hypothyroidism and the new website aims to help them understand more about the condition, how it manifests itself and what they can expect on the management journey.
"Effective management of the condition can significantly improve a dog’s quality of life and prevents the development of other, potentially life-threatening conditions, for which treatment can be intensive and costly."
The website also has a Frequently Asked Questions section and an interactive log book for owners to fill in which can also be emailed to their veterinary surgeon to assist in tracking the dogs’ progress and ensure that treatment is at its optimal level.
For more information, visit www.hypothyroiddog.com
The Horse Trust provides a range of services to support working horses, while Medical Detection Dogs trains dogs to alert their owners to cancers and other medical conditions, providing pre-emptive non-invasive warning.
Stephen said: "These two charities' work in strengthening and supporting the human-animal bond is truly remarkable. Though The Horse Trust was originally founded in 1886 as a retirement home for working horses, and this remains a core focus of theirs to this day, it has now evolved to provide a whole range of services, from education to research to rescuing neglected equids.
"Medical Detection Dogs, though founded much more recently in 2008, has already done an incredible amount in its short history - 76 of its dogs are now partnered with people with critical medical conditions, ensuring essential emotional as well as medical support."
Jeanette Allen, CEO of The Horse Trust, said: "The Horse Trust is extremely grateful to the RCVS for this enormously generous donation. We care for 130 horses, ponies and donkeys that have either retired from public service or been rescued from appalling conditions. We also provide dedicated training programmes for first responders who have to deal with horses in crisis situations, as well as being the second largest funder of equine specific veterinary research in the UK. We survive as a charity on donations, and this one is most welcome and greatly appreciated."
Claire Guest, co-founder and chief executive of Medical Detection Dogs, said: "We are so grateful to the RCVS for their very generous donation. We receive no government funding for our work, so we rely entirely on the generosity of organisations like the RCVS. Thanks to this donation, we can continue our pioneering research into the detection of human disease using the extraordinary smelling power of dogs."
The President’s Christmas Box donation is made every year in lieu of sending out RCVS Christmas cards. Previous recipients have included Worldwide Veterinary Service, Mind, Riding for the Disabled Association, Canine Partners, Hounds for Heroes, and Vetlife.
Despite the fact that homeopathic preparations are supposed to be diluted to the point where none of the original ingredient remains, the FDA says it has received increasing reports of products containing distinctly unhomeopathic quantities of things like belladonna being associated with serious adverse events.
The FDA has also had to issue warnings about homeopathic zinc-containing intranasal products which may cause a loss of the sense of smell and other homeopathic remedies which contain potentially toxic ingredients, such as nux vomica, which contains strychnine.
However, it is not just products with safety concerns that the new proposals are designed to address. Following in the footsteps of the NHS, the Australian National Health and Medical Research Council, The House of Commons Science and Technology Committee and more recently, the Royal College of Veterinary Surgeons and the European Academies Science Advisory Council (EASAC), the new FDA proposals highlight the risk from homeopathic remedies being marketed for serious diseases or conditions when they have not been shown to offer clinical benefits.
The proposals also highlight the risk to vulnerable populations that: "may also be at greater risk of harm as a result of foregoing the use of medical treatments that have been found safe and effective."
FDA Commissioner Scott Gottlieb, M.D. said: "In recent years, we’ve seen a large uptick in products labeled as homeopathic that are being marketed for a wide array of diseases and conditions, from the common cold to cancer.
"In many cases, people may be placing their trust and money in therapies that may bring little to no benefit in combating serious ailments, or worse – that may cause significant and even irreparable harm because the products are poorly manufactured, or contain active ingredients that aren’t adequately tested or disclosed to patients.
"Our approach to regulating homeopathic drugs must evolve to reflect the current complexity of the market, by taking a more risk-based approach to enforcement. We respect that some individuals want to use alternative treatments, but the FDA has a responsibility to protect the public from products that may not deliver any benefit and have the potential to cause harm."
VetSurgeon.org supports the Campaign for Rational Veterinary Medicine.
Photo: Multicolored homeopathy tubes isolated on a white background. Lush. Shutterstock.
A graduate of University College Dublin, Richard started out in first opinion practice after completing an internship at the University of Glasgow.
While studying medicine, Richard researched mast cell tumours in dogs, which led to an MSc in clinical Oncology. He went on to complete a PhD on mast cell tumours at the Royal Veterinary College in 2008.
Richard works with referral oncology patients and clients two days a week at LVS and currently spends the rest of his working week as an oncology consultant for IDEXX Laboratories.
From February, Richard will also be working at Southfield Veterinary Specialists in Laindon, Essex, thereby allowing him to refer oncology patients for radiation therapy at Southfields when necessary.
Richard said: "Having never been comfortable with operating myself, working with a team of this calibre and experience in a welcoming environment within central London was very attractive. It has been a very fulfilling role for me, especially as both our team and the scope of the services we can offer continue to expand.
"Given the high standard of care offered by local vets in the area, the patients referred to LVS are often very challenging. Together with our clients’ high expectations, the service is definitely not run-of-the-mill but all the more rewarding because of that.
"I’m looking forward to bringing my experience in both research and clinical spheres to LVS."
Richard’s main professional interests are mast cell tumours, novel diagnostics and immunotherapeutics, but he is experienced in all aspects of veterinary oncology and can also offer advice about internal medicine cases.
The website now contains a range of information on Alfaxan including user experiences, sections on best practice anaesthesia, webinars and details of Jurox’s anaesthesia roadshows.
The webinars include a presentation which explains how to use Alfaxan to achieve the best anaesthetic experience for the patient. There is also series of short online webinars on rabbit anaesthesia:
An online CPD certificate will be issued to veterinary professionals who have viewed each webinar, after they have taken a short online questionnaire.
The Alfaxan website also offers downloadable resources such as the new Considerations for Anaesthetising Rabbits expert panel guidelines booklet, AVA Anaesthetic Safety Checklist Implemenation manual, AVA Anaesthetic Safety Checklist and Alfaxan resource guides, user guides, dose charts and monitoring charts.
Richard Beckwith, country manager of Jurox (UK) Ltd, said: "Our new Alfaxan website is an educational hub that enables veterinary professionals to learn more about best practice anaesthesia and how this can be implemented in their own clinics. With Alfaxan’s new pet rabbit indication we have included an emphasis on rabbit anaesthesia and how this differs from anaesthesia in cats and dogs."
For further information, visit www.alfaxan.co.uk, contact your local Jurox technical sales representative, telephone the customer services team on 0800 500 3171 or e-mail: info@jurox.co.uk.
The RCVS Disciplinary Committee heard two charges against Dr Nemes, the first being that he had posted comments on social media about another veterinary surgeon, his employer, Dr Toth, which were offensive and/or derogatory and/or inappropriate.
The second charge was that Dr Nemes had posted his comments without having sufficient regard to maintaining their confidentiality and/or privacy.
Dr Nemes admitted the charges, though he did inform the Committee that his admission with respect to the second charge was caveated by the proposition that the comments were posted in private messages on Facebook with a limited membership, namely employees of Healers Veterinary Centre (Dr Toth’s practice).
The Committee noted the Respondent’s admissions as to the charges raised against him and pronounced the facts found proved.
In relation to the first charge, the Committee found that the comments on social media were, without a doubt, highly unprofessional. They included offensive language, were gratuitously personal against Dr Toth, and were made within an online chat which included junior lay staff, all employed by Dr Toth.
This behaviour was seen to directly contravene a numbers of parts of the RCVS Code of Professional Conduct, in particular Paragraph 5.3 that states: "Veterinary Surgeons and Veterinary Nurses should not speak or write disparagingly about another Veterinary Surgeon or Veterinary Nurse."
In relation to the second charge, the Committee found that Dr Nemes had paid no regard to maintaining the confidentiality and/or privacy of his malicious and damaging entries to the chat.
At the outset of his evidence, Dr Nemes admitted that the proven charges amounted to serious professional misconduct. The Committee noted however that the question of whether he was guilty of serious professional misconduct or not was in fact a matter for it to decide, notwithstanding his admission.
The Committee considered the fact that the period of time that Dr Nemes was involved in making postings was effectively about two weeks, that his involvement followed his wife’s dismissal from employment (representing a breach of Dr Nemes’ resignation conditions), and that he was very stressed at the time.
It also considered Dr Nemes’ point that he had never anticipated that Dr Toth would see the Facebook Messenger conversation, and that the relevant RCVS supporting guidance to the Code concerning good practice when using social media and online networking forums was only published in late November 2014 when Dr Nemes’ involvement in the conversation was virtually at an end.
In summing up, Ian Green, Chair of the Committee, said: "The Committee carefully considered the circumstances surrounding the Facebook Messenger entries which the Respondent posted from 13 November 2014. It noted that at the time he had handed in his resignation, morale at the practice was very low. The Facebook Messenger chat site had been started amongst the receptionist/animal carers. A perusal of the entries before the Respondent joined on 13 November 2014 demonstrates that morale was low among that group.
"…Notwithstanding the nature of the remarks posted on the Facebook Messenger, which the Committee deplores, it has reached the conclusion that, whilst the Respondent’s behaviour amounts to misconduct and falls short of the standards expected of a member of the veterinary profession, it does not amount to serious misconduct and does not fall far short.
"In the circumstances it has reached the unusual conclusion that, notwithstanding the Respondent’s admission, the appropriate finding is that he is not guilty of disgraceful conduct in a professional respect."
The new bill - Animal Welfare (Sentencing and Recognition of Sentience) - would increase the maximum prison sentence for animal cruelty tenfold, from six months to five years, in England and Wales.
The draft bill also sets out that the government "must have regard to the welfare needs of animals as sentient beings in formulating and implementing government policy".
Subject to consultation on the draft bill, the government says it will legislate to deliver both aims.
In fact, the draft bill goes further than Article 13 as it applies to all areas of government policy, rather than specified areas of policy. If passed, the law would apply to the whole of the UK.
Environment Secretary Michael Gove said: "Animals are sentient beings who feel pain and suffering, so we are writing that principle into law and ensuring that we protect their welfare. Our plans will also increase sentences for those who commit the most heinous acts of animal cruelty to five years in jail. We are a nation of animal lovers so we will make Brexit work not just for citizens but for the animals we love and cherish too."
BVA President John Fishwick said: "Vets have been clear in our calls that the duty on the state to have due regard for animal welfare - as captured in Article 13 of the EU Lisbon Treaty - must be enshrined in UK law. This Bill captures the substantive obligation that Article 13 currently puts on the national government to consider animal welfare, as well as explicitly recognising animals as sentient beings."
"Today’s draft Bill lays out in black and white the Government making good on its promises, to ensure the UK remains a global leader in animal welfare post-Brexit."
Centaur will continue to operate its warehouse in Castle Cary, Somerset; the new facility will allow the company to bolster its services to customers throughout Northern England, North Wales and Scotland.
AmerisourceBergen says the new Midlands facility will hold more than 13,000 products and be licensed for the wholesale distribution of veterinary and human medicines. The facility will use a state-of-the-art warehouse management software to provide efficient and accurate order fulfillment and improve the visibility of products in the supply chain.
Brian Topper, Managing Director of AmerisourceBergen Animal Health U.K. said: "Our expanded presence and capabilities in the U.K. is a reflection of the demand for high-quality solutions, and we’re growing to best meet our customers’ needs.
"Practices of all sizes rely on us to provide them with timely access to the products they need on a daily basis. With broader scope and capacity, we’ll be able to go beyond our best-in-class services and provide an unmatched customer experience by delivering critical products to practices in a more efficient and consistent manner than ever before."
The company says that the new warehouse will create more capacity at its Somerset warehouse and put the company in a positive inventory position to buffer against any business continuity challenges that may occur – ensuring that practices and their patients continue to have access to vital products.
Lisa Derbyshire, Director of Operations & Supply Chain at Centaur Services said: "As the industry moves forward, we want to ensure our customers have access to high-quality infrastructure that maximizes product safety and improves operational efficiency. Adding critical resources and upgraded service offerings, like our new distribution center in the Midlands, enables us to be at the forefront of distribution while continuing to provide the excellent service that our customers have come to know and expect from Centaur."
Paragon is being built by the Linnaeus Group, which says the new centre will be one of the largest and best-equipped in the UK when it opens its doors early in the New Year.
The new centre follows the Linnaeus Group's acquisition of Dewsbury-based Calder Vets last year.
Calder Vets' existing referral teams, together with two ophthalmologists from its Mirfield branch, will be transferring to Paragon. Meanwhile, Calder Vets will move to solely first-opinion work.
Currently nearing the end of construction, the centre will have eight consulting rooms, five operating theatres, MRI and CT scanners, intensive care facilities along with an all-digital imaging department.
A total of up to 80 staff will be employed at Paragon, including up to 18 referral vets and 32 veterinary nurses.
Specialist services will include cardiology, neurology, ophthalmology and orthopaedic and soft tissue surgery.
Positions currently available include a diagnostic imager, internal medicine specialist, neurology specialist, oncology specialist and an ophthalmologist, as well as various nursing posts.
Ian Monteith, managing director of Paragon, said: "We are looking for the best possible people who not only have the right skills and experience, but who will also fit into the ethos we want to create at Paragon.
"It is a significant and exciting opportunity for motivated, high calibre people to help shape something that has a very bright future for both the industry and for their own careers.
"Our philosophy is very much one of friendly cooperation between all members of staff, creating a pleasant, supportive and good-humoured atmosphere."
For details of the vacancies currently on offer at Paragon, visit www.paragonreferrals.co.uk/en-GB/careers
Entries for the awards, which were presented at a ceremony held at Wembley Stadium, came from a wide range of SMEs employing less than 250 employees, operating across all industries.
This latest achievement comes at the end of a successful year for the company, which saw it celebrate 80 years in business and recruit its 200th team member after creating 50 new jobs in the last 12 months alone. Earlier this year, White Cross Vets was also included in The Sunday Times ‘Best 100 Small Companies To Work For’ league table for the fifth year running.
Tim Harrison, Managing Director of White Cross Vets, said: "To be named as the UK’s best SME is an amazing achievement and we’re extremely proud of it. We take immense pride in making White Cross Vets a superb place to work and always strive to foster a close-knit and highly motivated team.
"As part of this we’ve further enhanced the wide range of employee benefits that our people enjoy this year, which ultimately translates into the level of care and standard of service that our clients receive. Winning the ‘Employer of the Year’ award reinforces this and cements our position at the forefront of the veterinary industry."
Damian Cummins, Awards Director, said: "White Cross Vets is a very worthy winner from the best of businesses across the UK, a great achievement and ambassador for SME’s."
Employment initiatives that White Cross Vets offers include days off and cakes for birthdays, five donation days a year to volunteer with chosen charities and a health care scheme as well as subsidised Fitbits and gym memberships.
The competition sees hundreds of veterinary practices around the country decorating their waiting rooms with fireworks-themed displays, with practices gaining extra recognition if they built a den. It aimed to highlight top tips for pet owners during the fireworks season and the benefits of building a den to help calm and reassure dogs during the firework festivities.
The winning veterinary practices, which were each awarded a luxury chocolate hamper, were:
It was Woodcroft Vets' entry that included the veterinary nurse starring as a witch; the credits at the end are worth waiting for!
Abbie King, product manager for Adaptil and Feliway at Ceva Animal Health, said: "We are always amazed by the enthusiasm and creativity from vet practice teams around the country when they decorate their waiting rooms to demonstrate the preventative measures clients can carry out at home to help manage their pets’ firework fears. There were some fabulous entries this year which made it really hard to identify just 11 winners."
For details on Adaptil and Feliway visit www.adaptil.com/uk or www.feliway.com/uk.
Redonyl Ultra contains essential fatty acids, Palmitoylethanolamide (PEA) and Biotin.
PEA is a naturally-occurring bio modulator which Dechra says has scientifically proven activity against the mechanisms that contribute to inflammation and pain, while Biotin is important for synthesis of fatty acids and support of optimal skin condition.
Dechra Brand Manager Claire Morgan said: "Redonyl Ultra is a great addition to Dechra’s extensive Dermatology range that allows an holistic approach to treatment, control and maintenance of dermatological conditions.
"Allergic skin conditions are among the most common causes of skin and ear disease in cats and dogs, and it is estimated that up to 15 per cent of dogs are affected by atopy. In situations where an allergen cannot be avoided, multi-modal therapy is useful to control the clinical signs."
Redonyl Ultra comes in a convenient bottle size of 60 skittle capsules, in two strengths for different sized animals. The capsules can be opened and given with food or ingested directly, or swallowed whole for flexible administration.
For more information, visit http://bit.ly/2iNa2Ik
The new law, which replaces the Data Protection Directive, come into effect from 25th May 2018. All businesses will be affected, including the veterinary profession, and failure to comply could result in heavy financial penalties. It is important, therefore, that all practices start to prepare for them and ensure that they will be compliant when the new legislation comes into play next year.
Renay Rickard, president of the VPMA said: "These new regulations concern how we will manage personal data, both that of our clients and our staff, and it’s imperative that we understand them and act on them. We arranged this webinar to inform our members, and were very lucky to have such a tailored presentation directly from the regulator – helped by the fact that Helen, the speaker, comes from a veterinary practice background. It was so useful, we felt that the wider veterinary community would benefit from listening to it, so we’re pleased to open it up to non-members."
The webinar content guides listeners through the key changes ahead and the steps that practices will need to take to ensure they are compliant with the new legal requirements. This includes the impact the changes will have on marketing strategies and practice positioning on sending client reminders (e.g. vaccination, appointment); sharing case histories; passing on data regarding 'bad-debtors', as well as how to approach 'tagging' clients records (for example, re debt) in compliance with the GDPR.
The webinar also provides useful information on where to turn if practices need help and advice, as well as what to do if a data breach is detected. Finally, a detailed questions and answers session covers the day-to-day scenarios in practice that involve handling or sharing client data.
The recording can be accessed on request by emailing the VPMA Secretariat, secretariat@vpma.co.uk.
Photo: GDPR - General Data Protection Regulation. data 25 may 2018. Map EU and flag. Shutterstock/a_Jarm
Sylvie, a four-month-old Maine Coon, was referred to NDSR with a loud heart murmur. Scans revealed she was suffering from a severe obstruction on the right side of her heart which was steadily becoming worse.
Her condition, double chambered right ventricle, is very rare and, until now, could only be corrected by open heart surgery. However, NDSR specialist cardiologist João Loureiro believed this would be too much of a risk for frail Sylvie, so he opted for a cutting balloon angioplasty which had never been applied to cats before because their hearts are so small.
He and fellow cardiology specialist Joel Silva carried out the procedure, which involved inserting two balloons on a wire into a vein in Sylvie’s neck and on to her heart. The first had four cutting blades, which were manipulated to score the obstruction before the second was gently inflated in order to relieve it. After the wire and balloons had been removed, the incision in Sylvie’s neck required just two stitches and within 48 hours she was well enough to return home.
A subsequent scan showed the level of obstruction had been reduced from severe to mild and her owner, Dr Bob Baxter, described her as “much more lively”.
João, who has a special interest in the treatment of congenital heart disease in small animals, said the decision to perform the interventional ballooning was made because of the risks of open heart surgery and the recent development of veterinary applications of the cutting balloon technique.
João said: "As Sylvie’s condition was so rare, wider application of the technique is limited in terms of the number of cats which could benefit from it. However, it is extremely relevant to those individuals who are affected and could be of use in the treatment of other, more common, conditions."
Joel said: "Cutting balloon angioplasty is routinely used in human medicine for treating narrowed and stiffened blood vessels and has recently been adapted to treat a heart condition in dogs but we believe this may be the first time it has been used to treat this condition in a cat."
Photo: Sylvie recovering with NDSR cardiology nurse Francesca Adams
95% of the vets surveyed by the company reported success treating cats with Thyronorm Oral Solution for Cats, while 89% expected the liquid solution to improve compliance in the management of hyperthyroidism.
93% also said they found Thyronorm gave them an easier way to offer cats a low dose, or an 'in-between' dose, as it can be titrated 'to effect' – meaning the dose of treatment can be varied more easily to suit the individual animal.
Feline hyperthyroid specialist Dr Sarah Caney said she is unsurprised by the survey results: "Treatment is complex for cats needing a low dose, or an ‘in between’ dose, as standard anti-thyroid tablets are only available in a small number of dose sizes and are not designed to be split, halved or quartered. Also, if a cat is on alternating doses, it can be difficult for carers to remember which dose is due today."
Rachel Crowe, Norbrook’s Companion Animal Senior Product Manager, said: "We are delighted that overall 99% of the 200 veterinary surgeons surveyed would recommend Thyronorm in the management of hyperthyroidism, compared to other medical options."
Thyronorm contains 5mg/ml of thiamazole (methimazole). The initial starting dose is 5mg active ingredient per day, split into two doses.
Available in 30ml and 100ml bottles, with an in-use shelf life of six months, Thyronorm is available to order from all UK veterinary wholesalers.
The company's charity of the year is chosen by employees at its annual conference in October. Fundraising then begins the following January.
This year, fundraising activities included cake sales, 'wearing blue days' and dog shows. Others took a more energetic approach: a team from Tone Veterinary Centre in Taunton cycled the equivalent of Land’s End to John O’Groats on exercise bikes over a fortnight, raising £525, while groomer Ceri James from Petherton Vets in Cardiff climbed Ben Nevis.
Simon Innes, CVS Chief Executive said: "Each year, thousands of cats, dogs, small animals and horses rely on the hospitals, clinics and rehoming services run by Blue Cross so it was a very natural charity for us to support and the overwhelming winner of last year’s vote.
"Yet again, our teams have surpassed themselves by really getting behind our fundraising efforts and showing great creativity and dedication to the task. Judging by some of the photos, they also seem to have had a great deal of fun. We held a group-wide charity day during July in which all parts of the business participated. It was a fantastic event and really showed the power of collective fundraising."
Matt Cull, Deputy Director of Fundraising at Blue Cross, said: "The dedication from CVS to fundraise for our pets through many different activities is so inspiring. We are very grateful to all the teams for helping Blue Cross as the money raised will assist us in helping thousands of pets in need and support our other charitable activities, such as our education programmes and bereavement support service. Pets change lives and with this generous help, we can change theirs."
Photo: Simon Innes CVS Group Chief Executive; Diane James, Blue Cross; Piers Gibbon, CVS Conference compere